Annotation
A German company that is specialised in the cultivation of mass amounts of the Hepatitis A virus in cell culture and its specific monoclonal antibodies is looking for a manufacturing agreement, as well as for partners interested in distributing their products to pharmaceutical or biotechnological companies. The products can be used for the development and manufacturing of diagnostic tools or for application in vaccine technology.
Offer description
Approximately 1.4 million clinical cases of Hepatitis A occur each year worldwide. In the United States, for example, Hepatitis A is a common cause of acute hepatitis and one of the most frequently reported vaccine-preventable diseases. There is actually an urgent need for viral antigen in order to develop diagnostic tools and for the application in vaccine technology. The German SME is one of the few in the world, which is specialised in producing mass amounts of the Hepatitis A virus in cell culture and owns different hybridoma clones in order to produce the corresponding specific monoclonal antibodies raised against Hepatitis A. They produce several different antibodies, and all methods necessary to analyze and validate the produced materials are well established. The SME has a first-hand operating experience since its foundation in 1985 for tissue culturing and virus cultivation. The subsequently purification and concentration of viral antigen or monoclonal antibodies are also part of the expert knowledge. The company disposes of comprehensive facilities including bio safety level 2 laboratories in order to produce under GMP (Good Manufacturing Practice) and GLP (Good Laboratory Practice) conditions. The company is looking for further distribution partners that have access to pharmaceutical or biotechnological companies which require large amounts of Hepatitis A antigen and its specific monoclonal antibodies for the production of diagnostic tools or the development of vaccines. Furthermore they would be interested in manufacturing agreements with companies that regularly require large amounts of the SME’s antigen and corresponding antibodies for their activities.
Innovations and advantages
- the company belongs to one of few worldwide which is able to produce Hepatitis A antigen in cell cultures and its specific monoclonal antibodies in the gram range - their products can be produced under GMP (Good Manufacturing Practice) and GLP (Good Laboratory Practice) conditions. - the viral antigen and the monoclonal antibodies are available at a highly concentrated and purified stage. - the SME’s flexibility allows to react to all demands and specific requirements of the respective users - vast experience in cell culture and virus cultivation
Technology keywords
06001005 Diagnostics, Diagnosis
06001006 Human vaccines
06001018 Virus, Virology / Antiobiotics / Bacteriology
06002001 Biochemistry / Biophysics
Market application codes
04002 Monoclonal Antibodies and Hybridomas
05001005 Molecular diagnosis
05001007 Other diagnostic
05007007 Other medical/health related (not elsewhere classified)
Intellectual property rights
Secret Know-how
Profile date
16.03.2019
Сотрудничество
Area of partner's activity
- Type of partner sought: distributor, industry - Specific area of activity of the partner: pharmaceutical or bitotech companies developing diagnostic tools or vaccines. In case of a distribution agreement the partner should have access to those companies - Tasks to be performed by the partner sought: distribute the products to relevant companies active in the development of diagnostic tools or vaccines. In case of a manufacturing agreement the partner has to specify their demands and specific requirements
Поделиться